Printer-friendly versionPrinter-friendly version

Prevention of viral hepatitis in Italy: lessons learnt and the way forward

Catania, Italy, November 7-8, 2002

Thursday, November 7, 2002

Session 1 Opening and objectives

Chair: Pietro Crovari (Genova) and Pierre Van Damme (Antwerpen)
09.00 - 09.30

  • Welcome
    Pietro Crovari (Genova)
  • Introduction of the participants
  • Objectives of the meeting:
    1. Overview of surveillance systems for infectious diseases and adverse events following vaccination;
    2. Update of the epidemiological situation on viral hepatitis;
    3. Evaluation of current prevention and control measures on viral hepatitis;
    4. Lessons learnt from the Italian experience: successes, problems and barriers to overcome, and the way forward.
  • Review of the meeting programme
  • Epidemiology, prevention, and control of viral hepatitis in Italy: an overview - Pre-meeting document 22 Kb (.doc)

 

Session 2 The health care system in Italy

Chair: Pietro Crovari (Genova) and Pierre Van Damme (Antwerpen)

09.30 - 09.50
Organisation of the health care system in Italy 230 Kb (.ppt)
Franco Splendori (Roma), Maria Grazia Pompa (Roma)

09.50 - 10.00
Discussion and lessons learnt  

Session 3 Surveillance systems in Italy

Chair: Pietro Crovari (Genova) and Pierre Van Damme (Antwerpen)

10.00 - 10.20
Integrated epidemiological system for acute viral hepatitis (SEIEVA) 599 Kb (.ppt)
Alfonso Mele (Roma)

10.20 - 10.50
Coffee break

10.50 - 11.20
Discussion and lessons learnt  
 

Session 4A Epidemiology of viral hepatitis in Italy

Chair: Pietro Crovari (Genova) and Pierre Van Damme (Antwerpen)

11.20 - 11.40
Epidemiology of hepatitis B and C in Italy from the eighties until now 272 Kb (.ppt)
Pietro Crovari (Genova)

11.40 - 12.00
Epidemiology of hepatitis A and E in Italy 1,921 Kb (.ppt)
Rosa Cristina Coppola (Cagliari)

12.00 - 12.05
Hepatitis E in Italy  158 Kb (.ppt)
Alessandro Zanetti (Milano)

12.05 - 12.30
Discussion and lessons learnt

12.30 - 12.50
Update on WHO GAVI European Regional Working Group and hepatitis B immunization 970 Kb (.ppt)
Nedret Emiroglu (Denmark)

12.50 - 14.00
Lunch

Chair: Alfonso Mele (Roma) and Peter Grob (Zurich)

14.00 - 14.20
Epidemiology of hepatitis B surface antigen mutants in Italy: role and consequences for vaccination programmes  779 Kb (.ppt)
Alessandro Zanetti (Milano)

14.20 - 14.40
Epidemiology of hepatitis B core/pre-core mutants in Italy 1,430 Kb (.ppt)
Maurizia Brunetto (Pisa)

14.40 - 15.00
Discussion and lessons learnt

15.00 - 15.15
Coffee break

Session 5A Prevention and control of viral hepatitis in Italy

Chair: Alfonso Mele (Roma) and Peter Grob (Zurich)

15.15 - 15.50
Prevention of hepatitis C and residual risk of HCV, HIV, and HBV infection following blood transfusion: results of an Italian study  82 Kb (.ppt)
Alessandro Zanetti (Milano)

15.50 - 16.10
Molecular tracing of HCV: options for control of hospital transmission 177 Kb (.ppt)
Filippo Ansaldi (Trieste), Giancarlo Icardi (Genova)

16.10 - 16.30
Discussion and lessons learnt

16.30 Close of the day and summary by the chairs
Conference dinner

Friday, November 8, 2002

Session 4B Epidemiology of viral hepatitis in Italy

Chair: Paolo Bonanni (Firenze) and Alessandro Zanetti (Milano)

09.00 - 09.20
Epidemiology of hepatitis D in Italy
Mario Rizzetto (Torino)

09.20 - 09.30
Discussion and lessons learnt

Session 5B Prevention and control of viral hepatitis in Italy

Chair: Paolo Bonanni (Firenze) and Alessandro Zanetti (Milano)

09.30 - 10.00
Programme of HBV vaccination targeted to risk groups - Long-term protection after hepatitis B vaccination in a cohort of exposed newborns 49 Kb (.ppt)
Tommaso Stroffolini (Roma), Alfonso Mele (Roma)

10.00 - 10.20
Prevention of hepatitis A during outbreaks and post exposure 275 Kb (.ppt)
Paolo Bonanni (Firenze)

10.20 - 10.40
Discussion and lessons learnt

10.40 - 11.00
Coffee break

11.00 - 11.20
The hepatitis A epidemic in Puglia, Italy: lessons learnt and application of prevention programmes 1,337 Kb (.ppt)
Pier Luigi Lopalco (Bari)

11.20 - 11.40
The new Italian guidelines for the use of hepatitis A vaccine 121 Kb (.ppt)
Elisabetta Franco (Roma)

11.40 - 12.00
Discussion and lessons learnt

12.00 - 13.30
Lunch

Session 6 Evaluation of viral hepatitis prevention and control measures in Italy
Chair: Giuseppe Giammanco (Catania) and Mark Kane (Seattle)

13.30 - 14.00
Evaluation framework of viral hepatitis prevention programmes: examples in Italy - Impact of ten years of universal hepatitis B vaccination programmes  418 Kb (.ppt)
Tommaso Stroffolini (Roma)  99 Kb (.ppt)
Paolo Bonanni (Firenze), Alfonso Mele (Roma)

14.00 - 14.30
Discussion and lessons learnt  

Session 7 Conclusions of the meeting

Chair: Giuseppe Giammanco (Catania) and Mark Kane (Seattle)

14.30 - 15.00
Presentation of the VHPB meeting conclusions 50 Kb (.ppt)
David FitzSimons (Switzerland)

15.00 - 15.30
Discussions

15.30
Close of the meeting

Tags: